Startseite Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review

  • Itai Gross , Yael Siedner-Weintraub , Ari Simckes und David Gillis EMAIL logo
Veröffentlicht/Copyright: 5. März 2015

Abstract

Antenatal type I Bartter syndrome (ABS) is usually identified by the presence of polyhydramnios, premature delivery, hypokalemia, metabolic alkalosis, hypercalciuria, and nephrocalcinosis caused by mutations in the Na-K-2Cl cotransporter (NKCC2)-encoding SLC12A1 gene. In this report, we describe a novel presentation of this syndrome with hypercalcemic hypercalciuric hyperparathyroidism, and review the literature of the variable atypical presentations of ABS.


Corresponding author: Dr. David Gillis, Department of Pediatrics, Hadassah University Hospital, Ein-Kerem, Jerusalem, Israel, Phone: 972-5078-74572, Fax: 972-26778966, E-mail: ,

References

1. Bhat YR, Vinayaka G, Sreelakshmi K. Antenatal Bartter syndrome: a review. Int J Pediatr. 2012;2012:857136.10.1155/2012/857136Suche in Google Scholar

2. Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Bartter’s and Gitelman’s syndromes: from gene to clinic. Nephron Physiol 2004;96:65–78.10.1159/000076752Suche in Google Scholar

3. Landau D. Potassium-related inherited tubulopathies. Cell Mol Life Sci 2006;63:1962–8.10.1007/s00018-006-6011-0Suche in Google Scholar

4. Fahlke C, Fischer M. Physiology and pathophysiology of ClC-K/barttin channels. Front Physiol 2010;1:155.10.3389/fphys.2010.00155Suche in Google Scholar

5. Ji W, Foo JN, O’Roak BJ, Zhao H, Larson MG, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008;40:592–9.10.1038/ng.118Suche in Google Scholar

6. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, et al. Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet 2002;360:692–4.10.1016/S0140-6736(02)09842-2Suche in Google Scholar

7. Lee EH, Heo JS, Lee HK, Han KH, Kang HG, et al. A case of Bartter syndrome type I with atypical presentations. Korean J Pediatr 2010;53:809–13.10.3345/kjp.2010.53.8.809Suche in Google Scholar PubMed PubMed Central

8. Yamazaki H, Nozu K, Narita I, Nagata M, Nozu Y, et al. Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis. Pediatr Nephrol 2009; 24:415–8.10.1007/s00467-008-0999-3Suche in Google Scholar PubMed

9. Brochard K, Boyer O, Blanchard A, Loirat C, Niaudet P, et al. Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. Nephrol Dial Transplant 2009;24:1455–64.10.1093/ndt/gfn689Suche in Google Scholar PubMed

10. Bettinelli A1, Viganò C, Provero MC, Barretta F, Albisetti A, et al. Phosphate homeostasis in Bartter syndrome: a case-control study. Pediatr Nephrol 2014;29:2133–8.10.1007/s00467-014-2846-zSuche in Google Scholar PubMed

11. Leonhardt A, Timmermanns G, Roth B, Seyberth HW. Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr 1992;120(4Pt1):546–54.10.1016/S0022-3476(05)82480-1Suche in Google Scholar

12. Rodríguez-Soriano J, Vallo A, Aguirre M. Bone mineral density and bone turnover in patients with Bartter syndrome. Pediatr Nephrol 2005;20:1120–5.10.1007/s00467-005-1901-1Suche in Google Scholar PubMed

Received: 2014-5-8
Accepted: 2015-1-29
Published Online: 2015-3-5
Published in Print: 2015-7-1

©2015 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Highlight: Thyroid
  3. Thyroid disorders revisited
  4. Genetic analysis of the paired box transcription factor (PAX8) gene in a cohort of Polish patients with primary congenital hypothyroidism and dysgenetic thyroid glands
  5. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases
  6. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients
  7. Evaluation of inflammatory and oxidative biomarkers in children with well-controlled congenital hypothyroidism
  8. Investigation of autoimmune diseases accompanying Hashimoto’s thyroiditis in children and adolescents and evaluation of cardiac signs
  9. Neonatal thyroid storm accompanied with severe anaemia
  10. Functional characterization of the novel sequence variant p.S304R in the hinge region of TSHR in a congenital hypothyroidism patients and analogy with other formerly known mutations of this gene portion
  11. Subclinical hypothyroidism as a rare cofactor in chronic kidney disease (CKD) – related anemia
  12. Cytometric analysis of perforin expression in NK cells, CD8+, and CD4+ lymphocytes in children with autoimmune Hashimoto’s thyroiditis – a preliminary study
  13. Papillary thyroid cancer and autoimmune polyglandular syndrome
  14. Review article
  15. Should radioiodine be the first-line treatment for paediatric Graves’ disease?
  16. Image in pediatric endrocrinology
  17. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease
  18. Original articles
  19. Novel mutations of DAX1 (NR0B1) in two Chinese families with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
  20. Rickets and vitamin D deficiency in Alaska native children
  21. Persistent elevation of fibroblast growth factor 23 concentrations in healthy appropriate-for-gestational-age preterm infants
  22. Parents’ experiences of having a baby with ambiguous genitalia
  23. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty
  24. Congenital adrenal hyperplasia in children – a survey on the current practice in the UK
  25. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome
  26. Influence of the body weight on the onset and progression of puberty in boys
  27. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples
  28. Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene
  29. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds
  30. Monitoring gonadotropin-releasing hormone analogue (GnRHa) treatment in girls with central precocious puberty: a comparison of four methods
  31. Dietary intake, body composition, and physical activity among young patients with type 1 diabetes mellitus
  32. Metabolic syndrome in obese children and adolescents in Serbia: prevalence and risk factors
  33. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy
  34. Patient reports
  35. 17α-Hydroylase/17,20-lyase deficiency related to P.Y27*(c.81C>A) mutation in CYP17A1 gene
  36. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature
  37. Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene
  38. Triple A syndrome with a novel indel mutation in the AAAS gene and delayed puberty
  39. Case report: long-term follow-up of a 45,X male with SHOX haploinsufficiency
  40. Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review
  41. Successful use of continuous subcutaneous hydrocortisone infusion after bilateral adrenalectomy secondary to bilateral pheochromocytoma
  42. Donohue syndrome: a new case with a new complication
  43. Euprolactinemic galactorrhea secondary to domperidone treatment
  44. 17βHSD-3 enzyme deficiency due to novel mutations in the HSD17B3 gene diagnosed in a neonate
  45. Two different patterns of mini-puberty in two 46,XY newborns with 17β-hydroxysteroid dehydrogenase type 3 deficiency
  46. Short communication
  47. Early onset hearing loss in autosomal recessive hypophosphatemic rickets caused by loss of function mutation in ENPP1
Heruntergeladen am 7.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0188/html
Button zum nach oben scrollen